CLODERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cloderm, and what generic alternatives are available?
Cloderm is a drug marketed by Epi Hlth and is included in one NDA.
The generic ingredient in CLODERM is clocortolone pivalate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clocortolone pivalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cloderm
A generic version of CLODERM was approved as clocortolone pivalate by TARO on April 21st, 2020.
Summary for CLODERM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 2 |
Patent Applications: | 4,108 |
Drug Prices: | Drug price information for CLODERM |
What excipients (inactive ingredients) are in CLODERM? | CLODERM excipients list |
DailyMed Link: | CLODERM at DailyMed |
Recent Clinical Trials for CLODERM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
WAYCro | Phase 1 |
Taro Pharmaceuticals USA | Phase 1 |
Promius Pharma, LLC | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CLODERM
US Patents and Regulatory Information for CLODERM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epi Hlth | CLODERM | clocortolone pivalate | CREAM;TOPICAL | 017765-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |